Evidence map›Paper›PMID 34815343›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Structure of the translating

Lunda Shen, Zhaoming Su, Kailu Yang, Cheng Wu, Thomas Becker, Deborah Bell-Pedersen, Junjie Zhang, Matthew S Sachs

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. High-resolution reconstruction of aRNA (New York, N.Y.) · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. A Gene fromJournal of fungi (Basel, Switzerland) · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Lunda ShenDepartment of Biology, Texas A&M University, College Station, TX 77843.ORCID 0000-0002-8438-1482
Zhaoming SuDepartment of Bioengineering, Stanford University, Stanford, CA 94305.ORCID 0000-0002-9279-1721
Kailu YangDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843.ORCID 0000-0002-8234-1997
Cheng WuDepartment of Biology, Texas A&M University, College Station, TX 77843.ORCID 0000-0003-2340-3788
Thomas BeckerDepartment of Biochemistry, Gene Center, Ludwig-Maximilians University Munich, 80539 Munich, Germany.
Deborah Bell-PedersenDepartment of Biology, Texas A&M University, College Station, TX 77843.ORCID 0000-0002-1639-8215
Junjie ZhangDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843.ORCID 0000-0002-7912-0819
Matthew S SachsDepartment of Biology, Texas A&M University, College Station, TX 77843; msachs@bio.tamu.edu.ORCID 0000-0001-9891-9223
Texas A&M University · USLudwig-Maximilians-Universität München · DEStanford University · US

Funding

Mechanisms of Circadian Clock Control of mRNA TranslationR35GM126966 · NIGMS · TEXAS A&M UNIVERSITY · PI Deborah Bell-Pedersen · 2018 to 2026
$6.6M
CryoEM Data Collection Facility Consortium at NCMIU24GM116787 · NIGMS · STANFORD UNIVERSITY · PI BULLITT, ESTHER, CHIU, WAH · 2016 to 2020
$3.1M
Acquisition of a 300 kV Electron Microscope for Structural BiologyS10OD021600 · OD · STANFORD UNIVERSITY · PI CHIU, WAH · 2016 to 2016
$2.0M
Determining genetic signatures of the cryptococcal response to Zoloft by an integrated approach combining transcriptome, translatome and genetic screensR21AI138158 · NIAID · TEXAS A&M UNIVERSITY · PI LIN, XIAORONG, SACHS, MATTHEW STEVEN · 2018 to 2019
$395k
NIAID NIH HHS R21 AI138158NIGMS NIH HHS R35 GM126966NIGMS NIH HHS U24 GM116787NIH HHS S10 OD021600
6 · The paper itself

Abstract

Ribosomes translate RNA into proteins. The protein synthesis inhibitor cycloheximide (CHX) is widely used to inhibit eukaryotic ribosomes engaged in translation elongation. However, the lack of structural data for actively translating polyribosomes stalled by CHX leaves unanswered the question of which elongation step is inhibited. We elucidated CHX's mechanism of action based on the cryo-electron microscopy structure of actively translating

Indexed as

AllelesBinding SitesConserved SequenceCryoelectron MicroscopyCycloheximideFungiHumansImage Processing, Computer-AssistedModels, MolecularMolecular ConformationMutationNeurosporaNeurospora crassaPeptide Chain Elongation, TranslationalPeptidesPeptidyl TransferasesCycloheximidePeptidesPeptidyl TransferasesProtein Synthesis InhibitorsRibosomal ProteinsRNA, Transfercryo-electron microscopyprotein synthesistranslation

Identifiers

PMID34815343
PMCPMC8640747
OpenAlexW3217462656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.